Prescott Group Capital Management’s Altimmune ALT Stock Holding History

Prescott Group Capital Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,875	Closed	-$10.6M	–	169
2016 Q4	$10.6M	Sell	10,875 -15,728	-59%	-$14.1M	2.23%	9
2016 Q3	$23.1M	Hold	26,603	–	–	4.94%	3
2016 Q2	$19.5M	Hold	26,603	–	–	4.69%	2
2016 Q1	$15.1M	Hold	26,603	–	–	3.59%	4
2015 Q4	$15.2M	Hold	26,603	–	–	3.48%	4
2015 Q3	$10.6M	Hold	26,603	–	–	2.56%	7
2015 Q2	$14.4M	Hold	26,603	–	–	2.86%	4
2015 Q1	$13M	Hold	26,603	–	–	2.61%	4
2014 Q4	$14.4M	Hold	26,603	–	–	2.36%	6
2014 Q3	$14.2M	Buy	26,603 +9,120	+52%	+$4.77M	2.8%	4
2014 Q2	$7.39M	Hold	17,483	–	–	1.3%	17
2014 Q1	$9.6M	Hold	17,483	–	–	1.81%	7
2013 Q4	$9.76M	Hold	17,483	–	–	1.85%	8
2013 Q3	$11M	Buy	17,483 +1,847	+12%	+$1.06M	2.34%	7
2013 Q2	$7.46M	Buy	+15,636	New	+$7.75M	1.75%	12

Other funds holding ALT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Quadrant Glendale, California $18M AUM 24.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Prescott Group Capital Management's ALT Position: Q1 2017 in Review

Prescott Group Capital Management sold out of Altimmune (ALT) in Q1 2017, closing a stake of 10,875 shares — an estimated $10.6M sold.

Prescott Group Capital Management first reported a position in ALT in Q2 2013 and held it in 15 quarters. The position peaked at $23.1M in Q3 2016. 71 funds tracked by Wall St. Rank hold ALT as of Q1 2017.

Prescott Group Capital Management reported no remaining Altimmune position as of Q1 2017 after selling out during the quarter.
Prescott Group Capital Management sold 10,875 Altimmune shares in Q1 2017, an estimated $10.6M.
Prescott Group Capital Management first reported a position in Altimmune in Q2 2013 and held it in 15 quarters.
Prescott Group Capital Management's Altimmune position peaked at $23.1M in Q3 2016.
71 funds tracked by Wall St. Rank held Altimmune as of Q1 2017.

Based on Prescott Group Capital Management's 13F filing for Q1 2017, filed 1 May 2017.